Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) EPS (Basic) (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of EPS (Basic) data on record, last reported at -$3.51 in Q4 2025.

  • For Q4 2025, EPS (Basic) fell 17.0% year-over-year to -$3.51; the TTM value through Dec 2025 reached -$13.48, down 29.87%, while the annual FY2025 figure was -$13.48, 32.03% down from the prior year.
  • EPS (Basic) reached -$3.51 in Q4 2025 per PRAX's latest filing, down from -$3.37 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.49 in Q2 2023 and bottomed at -$65.86 in Q4 2022.
  • Average EPS (Basic) over 4 years is -$7.8, with a median of -$2.92 recorded in 2024.
  • Peak YoY movement for EPS (Basic): tumbled 600.66% in 2023, then surged 82.93% in 2024.
  • A 4-year view of EPS (Basic) shows it stood at -$65.86 in 2022, then skyrocketed by 73.32% to -$17.57 in 2023, then soared by 82.93% to -$3.0 in 2024, then fell by 17.0% to -$3.51 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$3.51 in Q4 2025, -$3.37 in Q3 2025, and -$3.31 in Q2 2025.